These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28914736)

  • 1. Update on tauopathies.
    Lebouvier T; Pasquier F; Buée L
    Curr Opin Neurol; 2017 Dec; 30(6):589-598. PubMed ID: 28914736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauopathies: Mechanisms and Therapeutic Strategies.
    Tan CC; Zhang XY; Tan L; Yu JT
    J Alzheimers Dis; 2018; 61(2):487-508. PubMed ID: 29278892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare Tauopathies.
    Ali F; Josephs K
    Semin Neurol; 2019 Apr; 39(2):264-273. PubMed ID: 30925618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tau-pathies: neurodegenerative diseases with pathology involving tau protein].
    Pokryszko-Dragan A; Zagrajek MM; Słotwiński K
    Postepy Hig Med Dosw (Online); 2005; 59():386-91. PubMed ID: 16106240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in experimental modeling of the assembly of tau filaments.
    Ko LW; DeTure M; Sahara N; Chihab R; Vega IE; Yen SH
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):125-39. PubMed ID: 15615632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Overview on the Clinical Development of Tau-Based Therapeutics.
    Medina M
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Diagnostic and Therapeutic Strategies for Tauopathies.
    Coughlin D; Irwin DJ
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):72. PubMed ID: 28785992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further understanding of tau phosphorylation: implications for therapy.
    Medina M; Avila J
    Expert Rev Neurother; 2015 Jan; 15(1):115-22. PubMed ID: 25555397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.
    Josephs KA
    Mayo Clin Proc; 2017 Aug; 92(8):1291-1303. PubMed ID: 28778262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau protein as a differential biomarker of tauopathies.
    Sergeant N; Delacourte A; Buée L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope.
    Theunis C; Adolfsson O; Crespo-Biel N; Piorkowska K; Pihlgren M; Hickman DT; Gafner V; Borghgraef P; Devijver H; Pfeifer A; Van Leuven F; Muhs A
    J Alzheimers Dis; 2017; 56(2):585-599. PubMed ID: 28035925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the development of tau PET radiotracers and their clinical applications.
    Okamura N; Harada R; Furukawa K; Furumoto S; Tago T; Yanai K; Arai H; Kudo Y
    Ageing Res Rev; 2016 Sep; 30():107-13. PubMed ID: 26802556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited review: Animal models of tauopathies and their implications for research/translation into the clinic.
    Dujardin S; Colin M; Buée L
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):59-80. PubMed ID: 25428793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic status of CSF distinguishes rats with tauopathy from controls.
    Karlíková R; Mičová K; Najdekr L; Gardlo A; Adam T; Majerová P; Friedecký D; Kováč A
    Alzheimers Res Ther; 2017 Sep; 9(1):78. PubMed ID: 28934963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.
    Castellani RJ; Perry G
    J Alzheimers Dis; 2019; 67(2):447-467. PubMed ID: 30584140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent developments in tau-based therapeutics for neurodegenerative diseases.
    Medina M
    Recent Pat CNS Drug Discov; 2011 Jan; 6(1):20-30. PubMed ID: 21118095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on the role of tau in Alzheimer's disease. Implications for therapy.
    Medina M; Avila J
    Biochem Pharmacol; 2014 Apr; 88(4):540-7. PubMed ID: 24462919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two days of tau: a meeting focused on its biology and pathology.
    Skoulakis EM; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):953-4. PubMed ID: 20658983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.